Form 4: GoodRx Holdings Executive Douglas Joseph Hirsch Reports Stock Transactions
SEC Form 4 Filing
Douglas Joseph Hirsch, Chief Mission Officer at GoodRx Holdings, reports the conversion and disposal of Class B Common Stock and acquisition of Class A Common Stock on March 1, 2024.
Summary
- On March 1, 2024, Douglas Joseph Hirsch, Chief Mission Officer of GoodRx Holdings, engaged in transactions involving the company's stock.
- Hirsch converted 256,595 Restricted Stock Units into Class B Common Stock and then converted 145,258 shares of Class B Common Stock into Class A Common Stock.
- He also disposed of 111,337 shares of Class B Common Stock to cover tax obligations at a price of $7.79 per share.
- Following these transactions, Hirsch directly owns 5,138,890 shares of Class A Common Stock and 256,595 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares of Class A and Class B common stock.
Key Dates
| Date | Description |
|---|---|
| September 1, 2020 | Commencement of vesting for restricted stock units in 16 equal quarterly installments. |
| March 1, 2024 | Date of the reported stock transactions. |
| September 25, 2027 | Potential conversion date for Class B common stock if certain conditions are not met earlier. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.